id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0259-0008,FDA,FDA-2005-P-0259,Tab 1 - Pyridoxamine 100mg 60 Tablets Product Information,Supporting & Related Material,Background Material,2009-01-22T05:00:00Z,2009,1,,,2025-03-24T18:17:21Z,,0,0,09000064804444d9
FDA-2005-P-0259-0006,FDA,FDA-2005-P-0259,Memorandum from Council for Responsible Nutrition (CRN) to FDA DMB,Other,Memorandum,2009-01-22T05:00:00Z,2009,1,2009-01-22T05:00:00Z,,2025-03-24T17:55:53Z,,0,0,09000064804444f5
FDA-2005-P-0259-0004,FDA,FDA-2005-P-0259,"Letter from FDA Acting Associate Commissioner for Regulatory Affairs to Morgan, Lewis & Bockius LLP",Other,Letter(s),2009-01-22T05:00:00Z,2009,1,2009-01-22T05:00:00Z,,2025-03-24T17:40:09Z,,0,0,090000648082ab57
FDA-2005-P-0259-0011,FDA,FDA-2005-P-0259,"Attachment 2 - Letter Requesting to Review ""Grandfathered"" List and Make Additions/Suggestions as Appropriate",Supporting & Related Material,Background Material,2009-01-22T05:00:00Z,2009,1,,,2025-03-24T18:34:34Z,,0,0,09000064804444f8
FDA-2005-P-0259-0009,FDA,FDA-2005-P-0259,Tab 2 - Brain Products,Supporting & Related Material,Background Material,2009-01-22T05:00:00Z,2009,1,,,2025-03-24T18:22:42Z,,0,0,09000064804444da
FDA-2005-P-0259-0007,FDA,FDA-2005-P-0259,Letter of Correction from Council for Responsible Nutrition (CRN) to FDA DMB,Other,Correction(s),2009-01-22T05:00:00Z,2009,1,2009-01-22T05:00:00Z,,2025-03-24T17:58:47Z,,0,0,09000064804444f9
FDA-2005-P-0259-0012,FDA,FDA-2005-P-0259,"Attachment 3 - NNFA List of Dietary Supplement Ingredients in Use Before October 15, 1994",Supporting & Related Material,Background Material,2009-01-22T05:00:00Z,2009,1,,,2025-03-24T18:36:39Z,,0,0,09000064804444fb
FDA-2005-P-0259-0005,FDA,FDA-2005-P-0259,"Citizen Petition from BioStratum, Inc.",Other,Citizen Petition,2009-01-22T05:00:00Z,2009,1,2009-01-22T05:00:00Z,,2025-03-24T17:52:26Z,,0,0,09000064804444d8
FDA-2005-P-0259-0010,FDA,FDA-2005-P-0259,Attachment 1 - CRN List of Dietary Ingredients 'Grandfathered' Under DSHEA,Supporting & Related Material,Background Material,2009-01-22T05:00:00Z,2009,1,,,2025-03-24T18:24:38Z,,0,0,09000064804444f7
FDA-2005-P-0259-0003,FDA,FDA-2005-P-0259,Request for Comment on the Status of Pyridoxamine,Notice,Notice of Action Taken,2005-11-22T05:00:00Z,2005,11,2005-11-18T05:00:00Z,2005-12-20T04:59:59Z,2025-03-29T18:56:22Z,,0,0,09000064804444e1
FDA-2005-P-0259-0001,FDA,FDA-2005-P-0259,See FDA-2005-P-0259-0002,Supporting & Related Material,ACK-Acknowledgement Letter (Supporting and Related Material),2005-08-01T04:00:00Z,2005,8,,,2009-01-22T23:44:34Z,,0,0,09000064804444d4
FDA-2005-P-0259-0002,FDA,FDA-2005-P-0259,"Acknowledgement Letter from FDA DDM to BioStratum, Inc.",Other,Acknowledgement Letter/Receipt,2005-08-01T04:00:00Z,2005,8,,,2025-03-24T17:24:32Z,,0,0,09000064804444d7